Amitha SHETTY, Panneer SELVAM, Smitha SHETTY, Chrishma SHALOMITH

Formulation, optimization and evaluation of mucoadhesive microspheres of captopril

The objective of the present study was to develop mucoadhesive microspheres of captopril in order toachieve extended retention in upper gastro intestinal tract to enhance absorption and bioavailability. The microsphereswere prepared by emulsification method using different ratio of sodium alginate with captopril by cross-linking withcalcium chloride. Fourier-transform infrared spectroscopy study shows that captopril and other excipients arecompatible with each other. The effects of polymers concentration on drug release profile were investigated. Responsesurface methodology was applied to systemically optimize the drug release profile. Polymer to drug ratio and stirringspeed were selected as independent variables. Drug entrapment efficiency, percentage mucoadhesive and in vitro drugrelease after 6 hours were selected as dependent variables. Obtained microspheres were subjected to differentevaluation parameters such as percentage yield, particle size analysis, drug entrapment efficiency, percentagemucoadhesive, in vitro drug release, drug release kinetics and scanning electron microscopy. The optimized formulation(MM10) showed satisfactory drug entrapment efficiency of 80.34±1.8 %, percentage mucoadhesive of 95.75±1.2 andpercentage drug release after 6 hours of 26.08±0.45 %. Scanning electron microscopy analysis revealed that particleswere spherical with smooth surface. Particles were free flowing with average particle size of 51.43 μm. Better resultswere observed from optimized mucoadhesive microspheres of captopril, thereby improving the bioavailability due toprolong release of drug in stomach.

PDF

___

[1] Patil AS, Dandagi PM, Masthiholimath VS, Gadad AP, Najwade BK. Development and characterization of chronomodulated drug delivery system of captopril. Int J Pharma Investig. 2011; 1(4): 227-233.
[2] White WB. Clinical assessment of early morning blood pressure in patients with hypertension. Prev Cardiol. 2007; 10: 210–214. [CrossRef]
[3] Wilding IR, Davis SS, Bakhshaee M, Stevens HN, Sparrow RA, Brennan J. Gastrointestinal transit and systemic absorption of captopril from a pulsed release formulation. Pharm Res. 1992; 9(5): 654-660. [CrossRef]
[4] Abbasi S, Yousef G, Ansari AA, Samani SM. Formulation and in vitro evaluation of a fast-disintegrating/sustained dual release bucoadhesive bilayer tablet of captopril for treatment of hypertension crises. Res Pharm Sci. 2016; 11(4): 274-283.
[5] Shadab M, Ahuja A, Khar R, Baboota S, Chuttani K, Mishra AK et al. Gastroretentive drug delivery system of acyclovir-loaded alginate mucoadhesive microspheres: formulation and evaluation. Drug Deliv. 2011; 18(4): 255-264. [CrossRef]
[6] Sawant K, Patel M, Patel J, Mundada P. Formulation, optimization, characterization and in vivo anti-ulcer activity of esomeprazole magnesium trihydrate gastro-resistant microspheres. Int J Pharm Pharm Sci. 2014; 6(9): 198-204. [CrossRef]
[7] Garud A, Garud N. Formulation of mucoadhesive microspheres of rosiglitazone maleate and it’s in vitro evaluation using ionotropic gelation technique. Ars Pharm. 2015; 56(2): 101-107. [CrossRef]
[8] Katewongsa P, Lertsuphotvanit N, Phaechamud T. Cetirizine dihydrochloride/β-cyclodextrin inclusion complex by ethanol kneading for taste masking. Indian J Pharm Sci. 2017; 79(5): 758-767. [CrossRef]
[9] Shadab M, Ahuja A, Khar R, Baboota S, Chuttani K, Mishra AK et al. Gastroretentive drug delivery system of acyclovir-loaded alginate mucoadhesive microspheres: formulation and evaluation. Drug Deliv. 2011; 18(4): 255-264. [CrossRef]
[10] Akhtar N, Pathak K. Cavamax W7 composite ethosomal gel of clotrimazole for improved topical delivery: development and comparison with ethosomal gel. AAPS PharmSciTech. 2012; 13(1): 344–355. [CrossRef]
[11] Sindhumol PG, Sudhakaran CR. Formulation and optimization of floating microspheres of cefixime trihydrate by factorial design. IJPRS. 2018; 7(1): 55-71. [CrossRef]
[12] Madhavi M, Madhavi K, Jithan AV. Preparation and in vitro/in vivo characterization of curcumin microspheres intended to treat colon cancer. J Pharm Bioallied Sci. 2012; 4(2): 164–171. [CrossRef]
[13] Abbas Z, Marihal S. Gellan gum-based mucoadhesive microspheres of almotriptan for nasal administration: formulation optimization using factorial design, characterization, and in vitro evaluation. J Pharm Bioallied Sci. 2004; 6(4): 267-277. [CrossRef]
[14] Dandagi PM, Mastiholimath VS, Gadad AP, Iliger SR. Mucoadhesive microspheres of propranolol hydrochloride for nasal delivery. Indian J Pharm Sci. 2007; 69(3): 402–407.
[15] Verma S, Kumar V, Jyoti, Mishra DN. Formulation, evaluation and optimization of mucoadhesive microspheres of acyclovir. Bull Pharm Res. 2014; 4(1): 14-20.
[16] Yerragunta B, Jogala S, Chinnala KM, Aukunuru J. Development of a novel 3-month drug releasing risperidone microspheres. J Pharm Bioallied Sci. 2015; 7(1): 37–44. [CrossRef]
[17] Dey S, Pramanik S, Malgope A. Formulation and optimization of sustained release stavudine microspheres using response surface methodology. ISRN Pharm. 2011: 627623. [CrossRef]
[18] Sahoo SK, Mallick AA, Barik BB, Senapati PC. Formulation and in vitro evaluation of Eudragit® microspheres of stavudine. Trop J Pharm Res. 2005; 4(1): 369-375. [CrossRef]
[19] Prasanthi D, Yanmanagandla D, Sripada RD. Formulation and evaluation of linagliptin mucoadhesive microspheres. Int Res J Pharm. 2018; 9(5): 11-17. [CrossRef]
[20] Shivakumar HN, Patel R, Desai BG. Formulation optimization of propranolol hydrochloride microcapsules employing central composite design. Indian J Pharm Sci. 2008; 70(3): 408-413.
[21] Crcarevska MS, Dodov MG, Goracinova K. Chitosan coated Ca–alginate microparticles loaded with budesonide for delivery to the inflamed colonic mucosa. Eur J Pharm Biopharm. 2008; 68(3): 565-578. [CrossRef]
[22] Ige P, Agrawal K, Patil U. Enhanced in vitro dissolution of iloperidone using caesalpinia pulcherrima mucoadhesive microspheres. Beni–Univ J Basic Appl Sci. 2015; 4(1): 26–32. [CrossRef]
[23] Gaur PK, Mishra S, Kumar A, Panda BP. Development and optimization of gastroretentive mucoadhesive microspheres of gabapentin by Box-Behnken design. Artif Cells Nanomed Biotechnol. 2014; 42(3): 167-177. [CrossRef]